000			01425 a2200397 4500
005			20250514015639.0
264		0	_c20020212
008			200202s 0 0 eng d
022			_a0033-3158
024	7		_a10.1007/s002130100880 _2doi
040			_aNLM _beng _cNLM
100	1		_aStein, D J
245	0	0	_aThe selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. _h[electronic resource]
260			_bPsychopharmacology _cNov 2001
300			_a267-72 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnalysis of Variance
650	0	4	_aAnxiety Disorders _xdrug therapy
650	0	4	_aConfidence Intervals
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOdds Ratio
650	0	4	_aParoxetine _xtherapeutic use
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use
700	1		_aStein, M B
700	1		_aGoodwin, W
700	1		_aKumar, R
700	1		_aHunter, B
773	0		_tPsychopharmacology _gvol. 158 _gno. 3 _gp. 267-72
856	4	0	_uhttps://doi.org/10.1007/s002130100880 _zAvailable from publisher's website
999			_c11628232 _d11628232